Adherence to adalimumab therapy in Crohn's disease: a French multicenter experience. (Q51744365)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21061388%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

title

Adherence to adalimumab therapy in Crohn's disease: a French multicenter experience (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21061388%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

0 references

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21061388%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Abderrahim Oussalah

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21061388%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Laurent Peyrin-Biroulet

9

object named as

Laurent Peyrin-Biroulet

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21061388%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

2

David Laharie

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21061388%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

7

Xavier Hébuterne

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21061388%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

3

Jérôme Filippi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21061388%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Jean-Baptiste Chevaux

6

object named as

Jean-Baptiste Chevaux

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21061388%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

8

Marc-André Bigard

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21061388%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

author name string

Vincent Billioud

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21061388%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

1 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21061388%20AND%20SRC:MED&resulttype=core&format=json

Inflammatory Bowel Diseases

16 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21061388%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21061388%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21061388%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

152-159

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21061388%20AND%20SRC:MED&resulttype=core&format=json

The natural history of adult Crohn's disease in population-based cohorts

16 January 2020

cites work

1 reference

The potential for disease modification in Crohn's disease

21 January 2018

1 reference

Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis

21 January 2018

1 reference

Studies of compliance with delayed-release mesalazine therapy in patients with inflammatory bowel disease

21 January 2018

1 reference

Mercaptopurine metabolite results in clinical gastroenterology practice

21 January 2018

1 reference

Adherence to thiopurine treatment in out-patients with Crohn's disease.

21 January 2018

1 reference

Clinical significance of azathioprine active metabolite concentrations in inflammatory bowel disease

21 January 2018

1 reference

Efficacy and safety of tumor necrosis factor antagonists in Crohn's disease: meta-analysis of placebo-controlled trials

21 January 2018

1 reference

Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial

21 January 2018

1 reference

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

21 January 2018

1 reference

How do patients with inflammatory bowel disease want their biological therapy administered?

21 January 2018

1 reference

Medication non-adherence is associated with increased medical health care costs

21 January 2018

1 reference

Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis

21 January 2018

1 reference

Adherence rates with infliximab therapy in Crohn's disease.

21 January 2018

1 reference

The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications

21 January 2018

1 reference

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

21 January 2018

1 reference

Adalimumab: in Crohn's disease

21 January 2018

1 reference

Influence of Trough Serum Levels and Immunogenicity on Long-term Outcome of Adalimumab Therapy in Crohn's Disease

21 January 2018

1 reference

Trends in RA patients' adherence to subcutaneous anti-TNF therapies and costs.

21 January 2018

1 reference

Qualitative investigation of patient adherence to 5-aminosalicylic acid therapy in patients with ulcerative colitis

21 January 2018

1 reference

Patient trust-in-physician and race are predictors of adherence to medical management in inflammatory bowel disease

21 January 2018

1 reference

Predictors of medication adherence in inflammatory bowel disease.

21 January 2018

1 reference